Weight loss jabs like Ozempic can cut the risk of heart attacks or strokes by a fifth, a “game-changing” new study has found. The anti-obesity injections could reduce the risk in obese people ...
Obesity jabs could cut the risk of heart attacks and strokes in people even if they fail to lose much weight, according to an ...
Anti-obesity jabs could reduce the risk of heart attacks, strokes or heart failure in obese people regardless of the amount of weight they lose while on the drug, researchers have found.
Doctors say it will be the 'icing on the cake' if the medicines, which have been shown to cut heart attack and strokes, had a ...
The revolutionary jabs were a hot topic as more than 40,000 cancer experts gathered in Chicago for the world's largest cancer ...
FAT jabs could be the cancer hope of the future after early studies found they reduce the risk of tumours. The world’s top ...
Weight loss drugs such as Ozempic and Wegovy could cut the risk of obesity-related cancers by a fifth and bowel cancer by ...
Semaglutide once a week reduced risk of adverse outcomes in kidney patients by 24 percent, finds study published in The New ...
But investors seeking exposure through two newly launched weight-loss exchange traded funds need to ask if they are the best way to gain exposure to this generation of drugs, industry observers say.
A low-calorie sweetener called xylitol used in many reduced-sugar foods and consumer products such as gum and toothpaste may ...
Novo Nordisk’s diabetes drug Ozempic reduces the risk of kidney failure and death in patients who have both Type 2 diabetes ...